Tabula Rasa HealthCare completes the sale of SinfoníaRx and DoseMeRx

Moorestown-based Tabula Rasa HealthCare on Friday said it completed the sale of its SinfoníaRx business to Cureatr, following the sale of its DoseMeRx business to an affiliate of Fairlong Capital LLC earlier this year. The combined proceeds are $11 million.

“The successful sale of these two businesses, along with the sale of PrescribeWellness in August 2022, completes the strategic divestitures that we announced last year, advancing our commitment to focus on our core value-based markets,” Brian Adams, president and interim CEO of TRHC, said.

TRHC completed the sale of DoseMeRx, an advanced precision dosing tool, on Jan. 20. The sale of TRHC’s medication therapy management business, SinfoníaRx, closed on March 2.